monoclonal antibodies can be made to target cancer cells.
The antibodies are then bound to a drug - a radioactive or toxic substance, or a chemical that stops cancer cells growing and dividing
The antibodies bind to cancer cells to deliver the drug in a targeted way, without harming other body cells.